Cargando…
Amyotrophic lateral sclerosis alters the metabolic aging profile in patient derived fibroblasts
Aging is a major risk factor for neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). As metabolic alterations are a hallmark of aging and have previously been observed in ALS, it is important to examine the effect of aging in the context of ALS metabolic function. Here, using...
Autores principales: | Gerou, Margarita, Hall, Benjamin, Woof, Ryan, Allsop, Jessica, Kolb, Stephen J., Meyer, Kathrin, Shaw, Pamela J., Allen, Scott P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346650/ https://www.ncbi.nlm.nih.gov/pubmed/34044197 http://dx.doi.org/10.1016/j.neurobiolaging.2021.04.013 |
Ejemplares similares
-
C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis
por: Allen, Scott P, et al.
Publicado: (2019) -
Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis
por: Allen, Scott P, et al.
Publicado: (2019) -
Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients
por: Konrad, Csaba, et al.
Publicado: (2017) -
A Y374X TDP43 truncation leads to an altered metabolic profile in amyotrophic lateral sclerosis fibroblasts driven by pyruvate and TCA cycle intermediate alterations
por: Allen, Scott P., et al.
Publicado: (2023) -
Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis
por: Riancho, Javier, et al.
Publicado: (2020)